Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Poyomtip, Teera ^a   Suwandittakul, Nantana ^b   Sitthichot, Narumon ^b   Khositnithikul, Rommanee ^b   Tan Ariya, Peerapan ^a   Mungthin, Mathirut ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; MULTIDRUG RESISTANCE PROTEIN 1; QUININE; SODIUM PROTON EXCHANGE PROTEIN 1; ANTIMALARIAL AGENT; GROWTH FACTOR ACTIVATABLE NA H EXCHANGER NHE 1; GROWTH FACTOR-ACTIVATABLE NA-H EXCHANGER NHE-1; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN; PROTOZOAL DNA; SODIUM PROTON EXCHANGE PROTEIN;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CODON; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA POLYMORPHISM; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE; HUMAN; IC 50; IN VITRO STUDY; MALARIA; PLASMODIUM FALCIPARUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; CAMBODIA; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; METHODOLOGY; MYANMAR; PARASITOLOGY; POLYMERASE CHAIN REACTION; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

ANTIMALARIALS; CAMBODIA; DNA, PROTOZOAN; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYANMAR; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; QUININE; SODIUM-HYDROGEN ANTIPORTER; THAILAND;

EID: 84855374165     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-7     Document Type: Article

References (35)

1. World Health Organization, Global report on antimalarial drug efficacy and drug resistance 2000-2010 Geneva: WHO 2010
2. World Health Organization, Guidelines for the treatment of malaria Geneva: WHO 2006
3. The treament of malaria. White NJ, N Engl J Med 1996 335 800 806 10.1056/NEJM199609123351107 8703186 (Pubitemid 26296541)
4. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Looareesuwan S, Wilairatana P, Vanijanonta S, Kyle D, Webster K, Lancet 1992 i 367 370
5. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ, Trans R Soc Trop Med Hyg 1994 88 324 327 10.1016/0035-9203(94)90102-3 7974679 (Pubitemid 24206458)
6. Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand. Hüttinger F, Satimai W, Wernsdorfer G, Wiedermann U, Congpuong K, Wernsdorfer WH, Wien Klin Wochenschr 2010 122 Suppl 3 52 56 20924699
7. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Cooper RA, Ferdig MT, Su XZ, Ursos LM, Mu J, Nomura T, Fujioka H, Fidock DA, Roepe PD, Wellems TE, Mol Pharmacol 2002 61 35 42 10.1124/mol.61.1.35 11752204 (Pubitemid 34049510)
8. Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Cooper RA, Lane KD, Deng B, Mu J, Patel JJ, Wellems TE, Su X, Ferdig MT, Mol Microbiol 2007 63 270 282 10.1111/j.1365-2958. 2006.05511.x 17163969 (Pubitemid 44968124)
9. Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. Valderramos SG, Valderramos JC, Musset L, Purcell LA, Mercereau-Puijalon O, Legrand E, Fidock DA, PLoS Pathog 2010 6 1000887 10.1371/journal.ppat.1000887 20485514
10. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF, Nature 2000 403 906 909 10.1038/35002615 10706290 (Pubitemid 30130994)
11. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Sidhu AB, Valderramos SG, Fidock DA, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034 (Pubitemid 41139856)
12. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA, J Infect Dis 2006 194 528 535 10.1086/507115 16845638 (Pubitemid 44162666)
13. Dissecting the loci of low-level quinine resistance in malaria parasites. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, Wellems TE, Mol Microbiol 2004 52 985 997 10.1111/j.1365-2958.2004.04035.x 15130119 (Pubitemid 38916169)
14. Extensive genetic diversity in the Plasmodium falciparum Na+/H + exchanger 1 transporter protein implicated in quinine resistance. Vinayak S, Alam MT, Upadhyay M, Das MK, Dev V, Singh N, Dash AP, Sharma YD, Antimicrob Agents Chemother 2007 51 4508 4511 10.1128/AAC.00317-07 17923493 (Pubitemid 350209916)
15. Plasmodium falciparum Na+/H + exchanger 1 transporter is involved in reduced susceptibility to quinine. Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Baret E, Mosnier J, Amalvict R, Fusai T, Rogier C, Pradines B, Antimicrob Agents Chemother 2009 53 1926 1930 10.1128/AAC.01243-08 19273668
16. Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Nkrumah LJ, Riegelhaupt PM, Moura P, Johnson DJ, Patel J, Hayton K, Ferdig MT, Wellems TE, Akabas MH, Fidock DA, Mol Biochem Parasitol 2009 165 122 131 10.1016/j.molbiopara.2009.01.011 19428659
17. In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya. Okombo J, Kiara SM, Rono J, Mwai L, Pole L, Ohuma E, Borrmann S, Ochola LI, Nzila A, Antimicrob Agents Chemother 2010 54 3302 3307 10.1128/AAC.00325-10 20516285
18. In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H + exchanger. Meng H, Zhang R, Yang H, Fan Q, Su X, Miao J, Cui L, Yang Z, Antimicrob Agents Chemother 2010 54 4306 4313 10.1128/AAC.00321-10 20643902
19. Polymorphism of Plasmodium falciparum Na(+)/H(+) exchanger is indicative of a low in vitro quinine susceptibility in isolates from Viet Nam. Sinou V, Quang le H, Pelleau S, Huong VN, Huong NT, Tai le M, Bertaux L, Desbordes M, Latour C, Long LQ, Thanh NX, Parzy D, Malar J 2011 10 164 10.1186/1475-2875-10- 164 21669011
20. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR, Antimicrob Agents Chemother 2003 47 2418 2423 10.1128/AAC.47.8.2418-2423.2003 12878499 (Pubitemid 36919439)
21. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S, Antimicrob Agents Chemother 1999 43 2943 2949 10582887
22. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F, Malar J 2009 8 11 10.1186/1475-2875-8-11 19138391
23. Association of microsatellite variations of Plasmodium falciparum Na+/H + exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Andriantsoanirina V, Ménard D, Rabearimanana S, Hubert V, Bouchier C, Tichit M, Bras JL, Durand R, Am J Trop Med Hyg 2010 82 782 787 10.4269/ajtmh.2010.09-0327 20439955
24. In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H + exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo. Briolant S, Pelleau S, Bogreau H, Hovette P, Zettor A, Castello J, Baret E, Amalvict R, Rogier C, Pradines B, Malar J 2011 10 37 10.1186/1475-2875-10-37 21314947
25. Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Baliraine FN, Nsobya SL, Achan J, Tibenderana JK, Talisuna AO, Greenhouse B, Rosenthal PJ, Antimicrob Agents Chemother 2011 55 615 622 10.1128/AAC.00954-10 21078941
26. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675 10.1126/science.781840 781840
27. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield J, Haynes D, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 394674 (Pubitemid 10082023)
28. Plasmodium falciparum: A simple polymerase chain reaction method for differentiating strains. Wooden J, Gould EE, Paull AT, Sibley CH, Exp Parasitol 1992 75 207 212 10.1016/0014-4894(92)90180-I 1516668
29. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Duraisingh MT, Roper C, Walliker D, Warhurst DC, Mol Microbiol 2000 36 955 961 10.1046/j.1365-2958.2000.01914.x 10844681 (Pubitemid 30326539)
30. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
31. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K, Acta Trop 2010 113 190 194 10.1016/j.actatropica.2009.10.016 19879850
32. Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border. Phompradit P, Wisedpanichkij R, Muhamad P, Chaijaroenkul W, Na-Bangchang K, Acta Trop 2011 120 130 135 10.1016/j.actatropica.2011.07.003 21777558
33. Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Sanchez CP, Rotmann A, Stein WD, Lanzer M, Mol Microbiol 2008 70 786 798 18713316
34. Relationship between anti-malarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Hawley SR, Bray PG, Mungthin M, Atkinson JD, O'Neill PM, Ward SA, Antimicrob Agents Chemother 1998 42 682 686 9517951 (Pubitemid 28114827)
35. Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Mungthin M, Bray PG, Ridley RG, Ward SA, Antimicrob Agents Chemother 1998 42 2973 2977 9797235 (Pubitemid 28501235)